Why the study?
Does combined low-dose aspirin and cyclosporine inhibit cyclosporine-associated thromboxane synthesis without altering the antiplatelet effects of aspirin in healthy dogs?
Population
7 healthy dogs
Comparison
Combined low-dose aspirin and cyclosporine vs Low-dose aspirin, high-dose aspirin, and…
Design
Preclinical, randomized
Follow-up
7 days
Authors
Loading...
May attenuate cyclosporine platelet effects in dogs; hypothesis-generating, requires prospective validation before any clinical translation.
Does combined low-dose aspirin and cyclosporine inhibit cyclosporine-associated thromboxane synthesis without altering the antiplatelet effects of aspirin in healthy dogs?
In healthy dogs, low-dose aspirin inhibits cyclosporine-induced thromboxane synthesis without compromising the antiplatelet effects of aspirin.
Thomason et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: